Skip to content
Open access

Invasive fungal infections after liver transplantation: Risk factors and impact on mortality in a retrospective single-center cohort with propensity score matching.

Aug 2026 · Medicina clínica (Ed. impresa) · Vol 166 10, pp. 107592 · 0 citations · 31 references
Medicine

Abstract

Background

Invasive fungal infection (IFI) remains a serious complication after liver transplantation (LT). We evaluated IFI incidence within 180 days after LT, assessed the predictive performance of the neutrophil percentage-to-albumin ratio (NPAR) and MELD-Na for post-transplant IFI, and examined IFI-associated 1-year mortality.

Methods

We conducted a retrospective, single-center study of adult LT recipients between 2003 and 2024. Risk factors were analyzed using multivariable logistic regression. Survival was assessed with Kaplan-Meier curves and Cox proportional hazards models, including 1:1 propensity score matching.

Results

Among 426 LT recipients, 37 (9%) developed IFI, most commonly Candida species (n=25), followed by Aspergillus species (n=12). Risk factors were evaluated separately for Candida and Aspergillus infections. Compared with recipients without invasive Candida infection, those with Candida IFI had greater disease severity at transplant (MELD-Na≥19: 44% vs 29%), a higher prevalence of upper-tertile NPAR (56% vs 32%; p=0.023), increased need for postoperative renal replacement therapy (44% vs 7%; p<0.001), more frequent early reintervention (40% vs 10%; p<0.001), and higher rates of biliary complications (24% vs 8%; p=0.017). Recipients with invasive Aspergillus infection were more likely to have upper-tertile NPAR (67% vs 32%; p=0.018) compared with those without Aspergillus infection. Elevated NPAR independently predicted both Candida (OR 2.65, 95% CI 1.17-6.01) and Aspergillus IFI (OR 4.17, 95% CI 1.23-14.35), whereas MELD-Na was not associated with either infection. After matching, IFI was associated with significantly higher 1-year mortality (HR 6.73; 95% CI, 1.53-29.62).

Conclusion

Pre-transplant NPAR was associated with an increased risk of post-transplant IFI, particularly Candida infection, and may contribute to risk stratification pending external validation.

Read PDF

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.